21-46001245-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001848.3(COL6A1):​c.1823-8G>A variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00666 in 1,603,962 control chromosomes in the GnomAD database, including 179 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0055 ( 15 hom., cov: 34)
Exomes 𝑓: 0.0068 ( 164 hom. )

Consequence

COL6A1
NM_001848.3 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.00002660
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.103
Variant links:
Genes affected
COL6A1 (HGNC:2211): (collagen type VI alpha 1 chain) The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 21-46001245-G-A is Benign according to our data. Variant chr21-46001245-G-A is described in ClinVar as [Benign]. Clinvar id is 93837.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-46001245-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00549 (837/152324) while in subpopulation SAS AF= 0.0488 (236/4834). AF 95% confidence interval is 0.0437. There are 15 homozygotes in gnomad4. There are 522 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 15 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL6A1NM_001848.3 linkuse as main transcriptc.1823-8G>A splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000361866.8 NP_001839.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL6A1ENST00000361866.8 linkuse as main transcriptc.1823-8G>A splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_001848.3 ENSP00000355180 P1
COL6A1ENST00000498614.5 linkuse as main transcriptn.49G>A non_coding_transcript_exon_variant 1/61
COL6A1ENST00000463060.6 linkuse as main transcriptn.222-8G>A splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant 5

Frequencies

GnomAD3 genomes
AF:
0.00550
AC:
837
AN:
152206
Hom.:
15
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000627
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0488
Gnomad FIN
AF:
0.0171
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00494
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.00980
AC:
2382
AN:
242994
Hom.:
55
AF XY:
0.0126
AC XY:
1671
AN XY:
132348
show subpopulations
Gnomad AFR exome
AF:
0.000311
Gnomad AMR exome
AF:
0.00139
Gnomad ASJ exome
AF:
0.00309
Gnomad EAS exome
AF:
0.000110
Gnomad SAS exome
AF:
0.0509
Gnomad FIN exome
AF:
0.0170
Gnomad NFE exome
AF:
0.00374
Gnomad OTH exome
AF:
0.00858
GnomAD4 exome
AF:
0.00678
AC:
9839
AN:
1451638
Hom.:
164
Cov.:
32
AF XY:
0.00829
AC XY:
5991
AN XY:
722310
show subpopulations
Gnomad4 AFR exome
AF:
0.000508
Gnomad4 AMR exome
AF:
0.00112
Gnomad4 ASJ exome
AF:
0.00364
Gnomad4 EAS exome
AF:
0.0000505
Gnomad4 SAS exome
AF:
0.0491
Gnomad4 FIN exome
AF:
0.0177
Gnomad4 NFE exome
AF:
0.00365
Gnomad4 OTH exome
AF:
0.00814
GnomAD4 genome
AF:
0.00549
AC:
837
AN:
152324
Hom.:
15
Cov.:
34
AF XY:
0.00701
AC XY:
522
AN XY:
74484
show subpopulations
Gnomad4 AFR
AF:
0.000625
Gnomad4 AMR
AF:
0.00222
Gnomad4 ASJ
AF:
0.00317
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.0488
Gnomad4 FIN
AF:
0.0171
Gnomad4 NFE
AF:
0.00494
Gnomad4 OTH
AF:
0.00236
Alfa
AF:
0.00507
Hom.:
1
Bravo
AF:
0.00258
Asia WGS
AF:
0.0180
AC:
61
AN:
3478
EpiCase
AF:
0.00442
EpiControl
AF:
0.00427

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJul 12, 2016- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 27, 2015- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 11, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:2
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
COL6A1-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMay 06, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Bethlem myopathy 1A Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Collagen 6-related myopathy Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.24
DANN
Benign
0.61
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000027
dbscSNV1_RF
Benign
0.034
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs184666690; hg19: chr21-47421159; COSMIC: COSV62612586; COSMIC: COSV62612586; API